Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 November, 2019 16:56 IST
Torrent Pharma acquires brands from Novartis AG
Source: IRIS | 09 May, 2017, 09.52AM
Comments  |  Post Comment

Ahmedabad based Torrent Pharma announced that it has completed the acquisition of Regestrone and Pregachieve brands for India from global Pharma player Novartis AG. Switzerland. These brands are widely prescribed by Gynaecologists for the management of Abnormal Uterine bleeding, Peri & Post- menopausal symptoms and Infertility.

Women Healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased. Regestrone and Pregachieve will further fortify the Hormone Segment. The use of Hormones amongst the Gynaecologists is on an increase because of lifestyle changes.

This acquisition would reaffirm Torrent's commitment towards the key important therapy of women healthcare.

Shares of the company gained Rs 2.7, or 0.21%, to trade at Rs 1,293.70. The total volume of shares traded was 2,439 at the BSE (9.43 a.m., Tuesday).



Torrent Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer